CYP24A1 Expression Inversely Correlates with Melanoma Progression: Clinic-Pathological Studies
Open Access
- 20 October 2014
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (10) , 19000-19017
Abstract
The major role of 24-hydroxylase (CYP24A1) is to maintain 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) homeostasis. Recently, it has been discovered that CYP24A1 also catalyses the hydroxylation of 20(OH)D3, producing dihydroxy-derivatives that show very effective antitumorigenic activities. Previously we showed a negative correlation of vitamin D receptor (VDR) and CYP27B1 expression with progression, aggressiveness and overall or disease-free survivals of skin melanomas. Therefore, we analyzed CYP24A1 expression in relation to clinicopathomorphological features of nevi, skin melanomas and metastases. In melanocytic tumors, the level of CYP24A1 was higher than in the normal epidermis. The statistically highest mean CYP24A1 level was found in nevi and early stage melanomas. With melanoma progression, CYP24A1 levels decreased and in advanced stages were comparable to the normal epidermis and metastases. Furthermore, the CYP24A1 expression positively correlated with VDR and CYP27B1, and negatively correlated with mitotic activity. Lower CYP24A1 levels correlated with the presence of ulceration, necrosis, nodular type and amelanotic phenotypes. Moreover, a lack of detectable CYP24A1 expression was related to shorter overall and disease-free survival. In conclusion, the local vitamin D endocrine system affects melanoma behavior and an elevated level of CYP24A1 appears to have an important impact on the formation of melanocytic nevi and melanomagenesis, or progression, at early stages of tumor development.Keywords
This publication has 65 references indexed in Scilit:
- High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivativesBritish Journal of Cancer, 2011
- The Analysis of Receptor-binding Cancer Antigen Expressed on SiSo Cells (RCAS1) immunoreactivity within the microenvironment of the ovarian cancer lesion relative to the applied therapeutic strategyCell and tissue research, 2011
- L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functionsPigment Cell & Melanoma Research, 2011
- Expression of vitamin D receptor decreases during progression of pigmented skin lesionsHuman Pathology, 2011
- 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cellsAmerican Journal of Physiology-Cell Physiology, 2011
- Vitamin D and the Immune System: New Perspectives on an Old ThemeEndocrinology and Metabolism Clinics of North America, 2010
- PLX4032, a selective BRAF V600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF WT melanoma cellsPigment Cell & Melanoma Research, 2010
- Molecular actions of vitamin D contributing to cancer preventionMolecular Aspects of Medicine, 2008
- Pathways and products for the metabolism of vitamin D3 by cytochrome P450sccThe FEBS Journal, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007